Cargando…

Low Quality of Warfarin Therapy is Associated With Female Gender but Not With Polypharmacy in Patients With Atrial Fibrillation

Background: We examined the impact of polypharmacy on the quality of the anticoagulation therapy in patients with atrial fibrillation. We also examined the factors that affect the stability of warfarin therapy. Methods and Results: This retrospective study was conducted using data from 157 consecuti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takamoto, Kojiro, Sakamoto, Jun-ichi, Ito, Satoyasu, Kimura, Takeshi, Manabe, Eri, Shikata, Toshiyuki, Asakura, Masanori, Ishihara, Masaharu, Tsujino, Takeshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8110202/ https://www.ncbi.nlm.nih.gov/pubmed/33981231 http://dx.doi.org/10.3389/fphar.2021.651799

Ejemplares similares

Polypharmacy Is Associated With Accelerated Deterioration of Renal Function in Cardiovascular Outpatients
por: Sakamoto, Jun-ichi, et al.
Publicado: (2020)

Reduced lifespan of erythrocytes in Dahl/Salt sensitive rats is the cause of the renal proximal tubule damage
por: Manabe, Eri, et al.
Publicado: (2020)

Neutrophil/lymphocyte ratio elevation in renal dysfunction is caused by distortion of leukocyte hematopoiesis in bone marrow
por: Ito, Satoyasu, et al.
Publicado: (2019)

Effectiveness and Safety of Rivaroxaban versus Warfarin Among Nonvalvular Atrial Fibrillation Patients with Obesity and Polypharmacy
por: Alberts, Mark J., et al.
Publicado: (2022)

Reduction in Left Ventricular Ejection Fraction is Associated with Subsequent Cardiac Events in Outpatients with Chronic Heart Failure
por: Okuhara, Yoshitaka, et al.
Publicado: (2019)

Polypharmacy and effects of apixaban versus warfarin in patients with atrial fibrillation: post hoc analysis of the ARISTOTLE trial
por: Jaspers Focks, Jeroen, et al.
Publicado: (2016)

Relationship Between Lipoprotein(a) and Angiographic Severity of Femoropopliteal Lesions
por: Yanaka, Koji, et al.
Publicado: (2021)

Comparison of coronary atherosclerotic disease burden between ST‐elevation myocardial infarction and non‐ST‐elevation myocardial infarction: Non‐culprit Gensini score and non‐culprit SYNTAX score
por: Tanaka, Takamasa, et al.
Publicado: (2020)

Crosstalk between Iron and Arteriosclerosis
por: Naito, Yoshiro, et al.
Publicado: (2022)

Comparative Effectiveness and Safety of Rivaroxaban and Warfarin Among Nonvalvular Atrial Fibrillation (NVAF) Patients with Obesity and Polypharmacy in the United States (US)
por: Berger, Jeffrey S., et al.
Publicado: (2021)

Warfarin and atrial fibrillation: from ideal to real the warfarin affaire
por: Molteni, Mauro, et al.
Publicado: (2014)

Serial changes of L wave according to heart rates in a heart failure patient with persistent atrial fibrillation
por: Morisawa, Daisuke, et al.
Publicado: (2019)

Concerns about clinical efficacy and safety of warfarin in diabetic patients with atrial fibrillation
por: Yamagishi, Sho-ichi
Publicado: (2019)

The use of warfarin in veterans with atrial fibrillation
por: Bravata, Dawn M, et al.
Publicado: (2004)

Polypharmacy and Clinical Outcomes in Hospitalized Patients With Acute Decompensated Heart Failure
por: Ozasa, Neiko, et al.
Publicado: (2023)

Gender differences, polypharmacy, and potential pharmacological interactions in the elderly
por: Venturini, Carina Duarte, et al.
Publicado: (2011)

Anticoagulation Stability Depends on CHADS(2) Score and Hepatorenal Function in Warfarin-treated Patients, Including Those with Atrial Fibrillation
por: Odashiro, Keita, et al.
Publicado: (2017)

Risk of both intracranial hemorrhage and ischemic stroke in elderly individuals with nonvalvular atrial fibrillation taking direct oral anticoagulants compared with warfarin: Analysis of the ANAFIE registry
por: Shiozawa, Masayuki, et al.
Publicado: (2023)

Polypharmacy in patients with multiple sclerosis: a gender-specific analysis
por: Frahm, Niklas, et al.
Publicado: (2019)

Effects of pharmacist intervention on polypharmacy in patients with type 2 diabetes in Japan
por: Horii, Takeshi, et al.
Publicado: (2020)

Safety and Effectiveness of Apixaban Versus Warfarin in Japanese Patients with Nonvalvular Atrial Fibrillation Stratified by Renal Function: A Retrospective Cohort Study
por: Morimoto, Takeshi, et al.
Publicado: (2023)

Patients’ time in therapeutic range on warfarin among atrial fibrillation patients in Warfarin Medication Therapy Adherence Clinic
por: Lee, Siew Ling, et al.
Publicado: (2021)

Polypharmacy, Adverse Outcomes, and Treatment Effectiveness in Patients ≥75 With Atrial Fibrillation
por: Chen, Nemin, et al.
Publicado: (2020)

Initiation and Persistence with Warfarin Therapy in Atrial Fibrillation According to Ethnicity
por: Hansen, Carolina Malta, et al.
Publicado: (2012)

Improving outpatient warfarin use for hospitalized patients with atrial fibrillation
por: Touchette, Daniel R., et al.
Publicado: (2008)

Dabigatran Versus Warfarin for Direct Current Cardioversion in Atrial Fibrillation
por: Benamer, Sufyan, et al.
Publicado: (2016)

Effect of apixaban compared with warfarin on coagulation markers in atrial fibrillation
por: Christersson, Christina, et al.
Publicado: (2019)

NOACs vs. Warfarin for Stroke Prevention in Nonvalvular Atrial Fibrillation
por: Patel, Priya, et al.
Publicado: (2017)

Characteristics of warfarin under-prescription in older adults with atrial fibrillation
por: Rashid, Sana, et al.
Publicado: (2021)

Drug-related problems in hospitalized patients on polypharmacy: the influence of age and gender
por: Koh, Yvonne, et al.
Publicado: (2005)

Sex and gender differences in polypharmacy in persons with dementia: A scoping review
por: Trenaman, Shanna C, et al.
Publicado: (2019)

Examining warfarin underutilization rates in patients with atrial fibrillation: Detailed chart review essential to capture contraindications to warfarin therapy
por: Srivastava, Ajay, et al.
Publicado: (2008)

Atrial fibrillation bleeding risk and prediction while treated with direct oral anticoagulants in warfarin‐naïve or warfarin‐experienced patients
por: Perino, Alexander C., et al.
Publicado: (2022)

Effect of vitamin K(2) on the anticoagulant activity of warfarin during the perioperative period of catheter ablation: Population analysis of retrospective clinical data
por: Zhou, Zhi, et al.
Publicado: (2016)

Clinical utility of reticulocyte hemoglobin equivalent in patients with heart failure
por: Tahara, Saki, et al.
Publicado: (2022)

Safety and efficacy of uninterrupted treatment with edoxaban or warfarin during the peri‐procedural period of catheter ablation for atrial fibrillation
por: Naito, Kazuya, et al.
Publicado: (2020)

Exendin-4 Prevents Vascular Smooth Muscle Cell Proliferation and Migration by Angiotensin II via the Inhibition of ERK1/2 and JNK Signaling Pathways
por: Nagayama, Kosuke, et al.
Publicado: (2015)

Polypharmacy and health outcomes in atrial fibrillation: a systematic review and meta-analysis
por: Gallagher, Celine, et al.
Publicado: (2020)

Impact of Multimorbidity and Polypharmacy on Clinical Outcomes of Elderly Chinese Patients with Atrial Fibrillation
por: Kotalczyk, Agnieszka, et al.
Publicado: (2022)

Warfarin doses for anticoagulation therapy in elderly patients with chronic atrial fibrillation
por: de Padua Mansur, Antonio, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ldj7dhtkvj9hd0e1nrlel6eobb